Founded in 2003 and headquartered in Dolgoprudny, Russia, Pharmstandard PJSC is a private pharmaceutical company dedicated to manufacturing generic pharmaceuticals and medical equipment. The company's core mission is to provide high-quality, affordable healthcare solutions globally. Pharmstandard's product portfolio includes antifungal medicines, treatments for cough and cold, and sterilizing equipment. Serving a worldwide market, the company aims to enhance healthcare accessibility and efficacy through its diverse range of remedies.
Notable figures associated with Pharmstandard include Viktor Kharitonin, the Chairman, and Igor Krylov, the CEO. The company has achieved significant financial milestones, reporting a revenue of $638 million in 2017 and maintaining substantial assets and equity. With a workforce of approximately 6,450 employees as of 2015, Pharmstandard has made a considerable impact on the pharmaceutical industry by consistently delivering essential medical products and equipment.
